Perfil
Samuel Härgestam is the founder of EnginZyme AB, where he currently holds the title of Chief Operating Officer & Director.
He founded the company in 2014.
Cargos activos de Samuel Härgestam
| Empresas | Cargo | Inicio |
|---|---|---|
EnginZyme AB
 EnginZyme AB BiotechnologyHealth Technology EnginZyme AB is a Swedish company founded in 2014 by Samuel Härgestam, Robin Chatterjee, and Karim Engelmark Cassimjee. EnginZyme is based in Stockholm, Sweden, and has a multidisciplinary team of experts in biocatalysis, organic chemistry, enzyme and process engineering, as well as AI and machine learning. The company has developed a patented, cell-free biomanufacturing platform that combines the power of biology with the efficiencies of the chemical industry. EnginZyme aims to produce better, greener, and more affordable products sustainably. The company's enzyme immobilisation technology enables biomanufacturing without living organisms, resulting in lower costs and a smaller environmental footprint. The company has been recognized as a technology pioneer by the World Economic Forum and was selected for the Cleantech 100 list in 2022 and 2023. Karim Engelmark Cassimjee has been the CEO since 2014. | Fundador | 01/01/2014 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
EnginZyme AB
EnginZyme AB BiotechnologyHealth Technology EnginZyme AB is a Swedish company founded in 2014 by Samuel Härgestam, Robin Chatterjee, and Karim Engelmark Cassimjee. EnginZyme is based in Stockholm, Sweden, and has a multidisciplinary team of experts in biocatalysis, organic chemistry, enzyme and process engineering, as well as AI and machine learning. The company has developed a patented, cell-free biomanufacturing platform that combines the power of biology with the efficiencies of the chemical industry. EnginZyme aims to produce better, greener, and more affordable products sustainably. The company's enzyme immobilisation technology enables biomanufacturing without living organisms, resulting in lower costs and a smaller environmental footprint. The company has been recognized as a technology pioneer by the World Economic Forum and was selected for the Cleantech 100 list in 2022 and 2023. Karim Engelmark Cassimjee has been the CEO since 2014. | Health Technology |
- Bolsa de valores
- Insiders
- Samuel Härgestam
